Movahed 2016.
Methods | Randomised clinical trial with 3 treatment arms. Recruitment period unclear, conducted at University Hospital in Qazvin, Iran. | |
Participants |
Inclusion criteria: nulliparous women, 39 weeks gestation or over with Bishop score less than 4. Exclusion criteria: vaginal bleeding, membrane rupture, active genital herpes infection, history of myomectomy, non‐reassuring fetal heart status, history of heart disease. |
|
Interventions | 75 women randomised into 3 groups: 25 women received ISMN, 25 received transvaginal catheter and 25 received Laminaria. | |
Outcomes |
Maternal: interval between time of induction and cervical ripening, interval between oxytocin administration and full cervical dilatation, duration of second and third labour phases, mode of delivery, maternal complications. Neonatal: complications. |
|
Notes | Non‐English language. Laminaria not eligible as an intervention for this review. No data suitable for analysis. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Participants 'randomly divided' by choosing colourful cards. |
Allocation concealment (selection bias) | Unclear risk | No details given. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No evidence to the contrary. |
Selective reporting (reporting bias) | Low risk | No evidence to the contrary. |
Other bias | Unclear risk | No evidence to the contrary. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | No mention of suitable dummies used. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No details given. |